People on the Move
By

By
Here are the latest moves and promotions of employees of our DCAT Member Company community. To submit a request to be included in People on the Move, click here. From…

New Member Company Alert
By

By
Welcome to our Newest Member Companies! We are pleased to welcome the following companies to our DCAT Member Community.

Moderna Investing To Increase Supply of COVID-19 Vaccine
By

By
Moderna, a biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, reports that it is making new funding commitments to increase supply of its COVID-19 vaccine at its owned and…

US Gov’t To Provide COVID-19 Vaccines, Supplies to India
By

By
The US government is looking at options to provide US-made doses of AstraZeneca’s COVID-19 vaccine to India and is funding an expansion of manufacturing capacity for Biological E. Limited (BioE),…

EU Seeks To Increase Supply of Pfizer’s/BioNTech’s COVID-19 Vaccine
By

By
The European Commission is working with Pfizer and BioNTech, a Mainz, Germany-based immunotherapy company, on a new contract for their COVID-19 vaccine with the aim to deliver 1.8 billion doses…

US Gov’t Lifts Pause on J&J’s COVID-19 Vaccine
By

By
The US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have lifted a pause on the rollout of Johnson & Johnson’s (J&J) COVID-19 vaccine…

Avantor To Increase Single-Use Capacity; Sharp in $43-M Expansion
By

By
The latest from CDMOs, CMOs, and suppliers featuring Avantor, Sharp, Cytiva, Vetter, Rentschler Biopharma, PPD, Catalent, Bushu Pharma, and others. Chemical/Chemical API Manufacturing Charnwood Molecular Secures Funding for ExpansionCharnwood Molecular,…

Pharma COVID Roundup: News from AstraZeneca, Merck & Co., Gilead
By

By
The latest on COVID-19 vaccines/drugs and manufacturing from AstraZeneca, Merck & Co., Gilead Sciences, Dr. Reddy’s, Valneva, Inovio, and others. Manufacturing and supply of COVID-19 vaccines and drugs AstraZeneca Responds…

Business Continuity Planning After COVID-19
By

By
An upcoming DCAT benchmarking study is examining the lessons learned and risk-mitigation practices taken by bio/pharma companies and suppliers in the wake of the COVID-19 pandemic. What best practices can…

Global Pharma Briefs: News from Regeneron and Seattle Genetics
By

By
A roundup of news from the US (Regeneron, Seattle Genetics). US FDA OKs Regeneron’s Ebola Drug The US Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals’ Inmazeb (atoltivimab, maftivimab…